InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,160.98
(
0.65%
)
US TECH 100
17,508.40
(
0.51%
)
Dow Jones
38,804.02
(
0.33%
)
Brent Oil
83.51
(
0.46%
)
Bitcoin
63,940.71
(
-0.09%
)

Replies to post #16371 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #16371 on Momenta Pharmaceuticals, Inc. (MNTA)

DewDiligence

01/13/17 10:35 AM

#16372 RE: t57 #16371

Under current regs, FDA is supposed to prioritize ANDAs for the first-to-market generics for branded drugs whose exclusivity is soon to expire. So, that's a positive for MNTA.